Science and Technology Innovation Program
Research Needs and Priorities Related to the Environmental, Health, and Safety Aspects of Engineered Nanoscale Materials
Testimony by Andrew D. Maynard, Ph.D.Chief Science Advisor Project on Emerging Nanotechnologies
What are the possible risks and benefits of nanotechnology and consumer products? In an effort to reach out to the American public and engage them in an important online conversation about the issue, the Project on Emerging Nanotechnologies is collaborating with Consumers Union – publishers of Consumer Reports magazine and Consumer Reports Online.
The next industrial revolution will fundamentally change the way we make things, and where. Government needs to create policy frameworks that support the transition to a new manufacturing paradigm and we also need to have a public conversation about what this world should look like and what policies are needed to make sure that both society and the planet will benefit.
Jean Lipman-Blumen, Thornton F. Bradshaw Professor of Public Policy at the Peter F. Drucker Graduate School of Management, Claremont Graduate University, and author of The Connective Edge: Leading in an Interdependent World and Hot Groups: Seeding Them, Feeding Them, and Using Them to Ignite Your Organization, co-written with Harold J. Leavitt. In this interview, Dr. Lipman-Blumen talks about connective leadership, hot groups, and the relationship between innovation and failure in organizations.
RFID technology could improve traffic flow, encourage recycling, and inform consumers if implemented responsibly.
There has been little change in public awareness of either synthetic biology or nanotechnology since previous surveys, according to this 2013 poll of more than 800 U.S. adults. In the poll, 23 percent of adults say they have heard a lot or some about synthetic biology, compared with 31 percent who say the same about nanotechnology. The most common associations that respondents make with synthetic biology are that it is unnatural, man-made, and artificial or that it has to do with reproducing life.
In New Life, Old Bottles: Regulating First-Generation Products of Synthetic Biology, Michael Rodemeyer examines the benefits and drawbacks of using the existing U.S. regulatory framework for biotechnology to cover the new products and processes enabled by synthetic biology. The safety of early applications of synthetic biology may be adequately addressed by the existing regulatory framework for biotechnology, especially in contained laboratories and manufacturing facilities, according to the report. But further advances in this emerging field are likely to create significant challenges for U.S. government oversight.